TDACU — Translational Development Acquisition Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsAdventurousMicro Cap

Annual balance sheet for Translational Development Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	—	USG	USG	USG
Status:	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.002	0.002	0.438	0.03
Prepaid Expenses
Total Current Assets	0.054	0.002	0.65	0.039
Long Term Investments
Other Long Term Assets
Total Assets	0.437	0.002	175	182
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.459	0.51	0.21	0.544
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.459	0.51	6.25	6.58
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.022	-0.508	169	175
Total Liabilities & Shareholders' Equity	0.437	0.002	175	182
Total Common Shares Outstanding